A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus–Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study

BACKGROUND: Patients with primary membranous nephropathy (MN) and persistent nephrotic syndrome have a high risk of progression to end-stage renal disease. The Ponticelli protocol (steroids with alkylating agents) is the most effective immunosuppressive therapy for this condition, but it has severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-Rivera, Jorge, Fernández-Juárez, Gema, Ortiz, Alberto, Hofstra, Julia, Gesualdo, Loreto, Tesar, Vladimir, Wetzels, Jack, Segarra, Alfons, Egido, Jesus, Praga, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581392/
https://www.ncbi.nlm.nih.gov/pubmed/26413273
http://dx.doi.org/10.1093/ckj/sfv075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581392/
https://www.ncbi.nlm.nih.gov/pubmed/26413273
http://dx.doi.org/10.1093/ckj/sfv075

Ejemplares similares